助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[18]条 当前为第1条到18条
 

相关语句
型肝炎
    Relation between Serum Trace Elements and Products of Lipid Peroxidation in Patients with Hepatitis B:A Clinical Epidemiological Study
    乙型肝炎患者血清微量元素与脂质过氧化产物相关性的临床流行病学研究
    Estahhshment of a second generation of national reference panels of quahlity control for hepatitis C diagnostic reagents in China
    第二代丙型肝炎诊断试剂质量控制参考品的建立
    Application of Cost - effect Analysis in Three Therapeutic Schemes for Chronic Hepatitis B
    3种慢性乙型肝炎治疗方案的成本-效果分析
    A Comprison of Cost-effectiveness Between Interferon α-2b and Lamivudine in Treating Chronic Hepatitis B
    干扰素α-2b与拉米夫定治疗慢性乙型肝炎的成本-效果分析
    Therapeutic effect of adefovir anti-duck hepatitis B virus in vivo and anti-HBV activity in vitro (2.2.15 cells)
    阿的福韦在鸭乙型肝炎模型及2.2.15细胞中抗乙型肝炎病毒的药效研究
    New drug for hepatitis C treatment--peginterferon alfa-2a
    治疗丙型肝炎的新药——聚乙二醇化干扰素α-2a
    New drug for the treat ment of chronic hepatitis B:peginterferon alfa-2a
    治疗慢性乙型肝炎的新药——聚乙二醇化干扰素α-2a
    Pharmacology and clinical application of PEG interferon alfa-2a on the Hepatitis C
    PEG-IFNα-2a治疗丙型肝炎的药理基础及临床应用
    Interferon alpha (IFN-α) has been proven to be effective in the treatment of chronic hepatitis B patients, which can decrease viral tite and improve liver function.
    α-干扰素(Interferon alpha,IFN-α)是目前临床治疗乙型肝炎的有效药物,它能有效地降低乙肝病人血清中的病毒滴度,改善肝功能。
    But long-term response of chronic hepatitis B for IFN-α treatment is low and the cost is expensive.
    然而,IFN-α治疗慢性乙型肝炎的长期应答率低,疗程长,费用昂贵,还有一定的副作用。
    Hepatitis B Virus (HBV) has been identified as a major cause of infectioushepatitis.
    乙型肝炎是一种高发性传染性疾病,由乙型肝炎病毒(hepatitis B virus,HBV)感染肝细胞后引起的。
    It apptared peak feature, 100 cases of liver deseases were analysed too, and the result indicated that the group of pa ieutswith acute hepatitis was the highest in SLPO, X±S: 9.44±1.81umol/L (N=60). The exnerimeut resuelt indicated that LPO might be related to the injured cell membrance
    对肝脏病100例分析表明:急性黄疸型肝炎组最高,9.44±1.81umol/L(n=60)实验结果表明LPO与细胞膜损伤有关。
    Thirty-one pathents(M21.F10;age 33 ± s 6 a) with chronic hepatitis B were treated with aciclovir 750 mg in Ringer's solution 500 mL iv,gtt. qd for 1 mo.
    静脉滴注阿昔洛韦治疗慢性乙型肝炎患者31例(男性21例,女性10例;年龄33±s6a),750mg,qd,共1mo。
    METHODS: Using pharmacoeconomical cost - effect analysis, three therapeutic schemes for chronic hepatitis B, including A, B and C schemes, were compared.
    方法:运用药物经济学成本-效果分析法对3种慢性乙型肝炎治疗方案,即对A、B、C方案进行回顾性分析评价。
    Methods Contents of serum HBV DNA and LN,HA,PⅢ,Ⅳ C in 30 patients with chronic active hepatitis B before treatment and 3,6,9 months after Lamivudine treatment were determined by PCR? Flourescence quantity and competitive radioimmunoassay respectively.
    方法 对 30例慢性活动性乙型肝炎患者治疗前和拉米夫定治疗 3、6、9个月后的血清 ,分别采用荧光全定量PCR法测定HBVDNA浓度和竞争性放射免疫法测定层粘连蛋白(LN)、透明质酸 (HA)、Ⅲ型前胶原 (PⅢ )、Ⅳ型胶原 (ⅣC)水平并进行比较。
    PEG-IFNα-2a is the most important compound for hepatitis C in the current clinical research. At present,the author introduced the pharmacodynamics and pharmacokinetics of PEG-IFNα-2a. Furthermore,by comparing the results of IFNα-2a from clinical experiments,the advantage and disadvantage of PEG-IFNα-2a were also shown in this paper.
    PEG-IFNα-2a是临床研究中治疗丙型肝炎的重要药物,简述了PEG-IFNα-2a的药效学、药动学,并通过比较PEG-IFNα-2a与IFNα-2a的临床应用研究报告,介绍了PEG-IFNα-2a治疗丙型肝炎的优点和不良反应。
    Results The morbidity and mortality of fulminant hepatitis was both higher in group 1(31% and 22%) than that in group 2(20% and 17%).
    结果HRZ联合化疗组暴发型肝炎的发生率为31%(16/51),死亡率为22%(11/51);
    Methods: One-day-old Yingtao Gu ducklings infected with positive serum of DHBV were used as the hepatitis B animal model.
    方法:用DHBV阳性血清感染1日龄的樱桃谷鸭,制备鸭乙型肝炎模型。
 

首页上一页1下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社